Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
66.37%Cash to Assets Ratio
VS
Market
Sector
Industry
History
$ 14.26Close
$ 8.21 - $ 14.6 52-Week Range
Ticker Information
Ticker
TBPHCompany Name
THERAVANCE BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTHERAVANCE BIOPHARMA INC - Cash to Assets Ratio Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TBPH - Cash to Assets Historical data
| Date | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
|---|---|---|---|
| 6/30/2025 | $ 426.04M | $ 282.76M | 66.37% |
| 3/31/2025 | $ 343.58M | $ 111.45M | 32.44% |
| 12/31/2024 | $ 354.16M | $ 38.63M | 10.91% |
| 9/30/2024 | $ 356.11M | $ 24.21M | 6.8% |
| 6/30/2024 | $ 362.03M | $ 47.18M | 13.03% |
| 3/31/2024 | $ 371.31M | $ 54.67M | 14.72% |
| 12/31/2023 | $ 382M | $ 40.38M | 10.57% |
| 9/30/2023 | $ 413.59M | $ 72.52M | 17.53% |
| 6/30/2023 | $ 446.63M | $ 106.43M | 23.83% |
| 3/31/2023 | $ 538.55M | $ 188.5M | 35% |
Key Performance Insights, Last 5 Years
- THERAVANCE BIOPHARMA INC's latest trailing twelve months (TTM) Cash to Assets stands at 18.38%.
- Over the past 5 years, THERAVANCE BIOPHARMA INC's average Cash to Assets has been 27.78%.
- The median Cash to Assets for THERAVANCE BIOPHARMA INC during this period was 24.33%
- THERAVANCE BIOPHARMA INC reached its highest Cash to Assets over the past 5 years at 66.37%.
- The lowest Cash to Assets recorded by THERAVANCE BIOPHARMA INC in the same timeframe 6.8%
THERAVANCE BIOPHARMA INC's Cash to Assets vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Cash to Assets Benchmarks
Similar metrics to Cash to Assets:
- Debt to Assets Ratio - [Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
- Core Assets - [Calculation] The core assets of a company represents the total [Assets] minus cash & equivalents [CashnEq] minus intangibles & goodwill [Intangibles].
- Cash and Equivalents - [Balance Sheet] Cash and cash equivalents are the sum of [Assets] that are cash or can be converted to cash in less than one year.
- Cash Ratio - [Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
- Inventory to Assets Ratio - [Calculation] [Inventory] as percentage of total [Assets], serves as an efficiency ratio - the lower the better.
Definition of Cash to Assets Ratio
[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].CashnEq / Assets
(=) Cash to Assets Cash to Assets for THERAVANCE BIOPHARMA INC is calculated as follows: CashnEq [ $ 94.11M ] / Assets [ $ 512.19M ]
(=) Cash to Assets [ 18.38% ] TBPH - Cash to Assets Ratio, Last 5 years
6.8%
Minimum
Sep 30, 2024
66.37%
Maximum
Jun 30, 2025
27.78%
Average
24.33%
Median
Cash to Assets Benchmark AnalysisMarket
The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.84% with a standard deviation of 9.62%.
The following table provides additional summary stats:
Cash to Assets in the Market:
| filtered constituents | 3.95K |
|---|---|
| min | 0% |
| max | 40.92% |
| average | 9.84% |
| median | 6.44% |
| std | 9.62% |